- SPL UNCLASSIFIED SECTION
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NYSTATIN
nystatin ointmentProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70771-1357 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NYSTATIN (UNII: BDF1O1C72E) (NYSTATIN - UNII:BDF1O1C72E) NYSTATIN 100000 U in 1 g Inactive Ingredients Ingredient Name Strength MINERAL OIL (UNII: T5L8T28FGP) PETROLATUM (UNII: 4T6H12BN9U) Product Characteristics Color YELLOW (YELLOW) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70771-1357-1 15 g in 1 TUBE; Type 0: Not a Combination Product 08/08/2018 2 NDC:70771-1357-2 30 g in 1 TUBE; Type 0: Not a Combination Product 08/08/2018 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA207767 08/08/2018 Labeler - Cadila Healthcare Limited (918596198) Registrant - Cadila Healthcare Limited (918596198) Establishment Name Address ID/FEI Business Operations Cadila Healthcare Limited 650650802 ANALYSIS(70771-1357) , MANUFACTURE(70771-1357)